Antibodies Directed Against Hepatitis C Virus E1E2 Complex, Compositions of HCV Particles, and Pharmaceutical Compositions
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
N/A
app pub date -
May 8, 2015
filing date -
Apr 1, 2003
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
Antibodies and antigen-binding molecules directed against Hepatitis C virus (HCV) are presented. The antibodies and antigen-binding molecules specifically bind to the HCV E1E2 complex. Also provided are pharmaceutical compositions containing the antibodies and/or antigen-binding molecules. Nucleic acids encoding the antibodies and antigen-binding molecules, along with corresponding expression vectors and host cells are also provided.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully